SMTL ID : 1bvr.3 (2 other biounits)

M.TB. ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH NAD+ AND C16-FATTY-ACYL-SUBSTRATE

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 27 residues within 4Å: Chain A: G.13, I.14, I.15, S.19, I.20, F.40, L.62, D.63, V.64, Q.65, S.93, I.94, G.95, I.121, M.146, D.147, F.148, Y.157, M.160, K.164, A.190, G.191, P.192, I.193, T.195, M.198 Ligands: THT.2 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:F.148, A:A.190 Hydrogen bonds: A:G.13, A:I.20, A:D.63, A:V.64, A:I.94, A:G.95, A:K.164, A:I.193, A:I.193, A:T.195 Water bridges: A:I.14, A:T.16, A:F.40, A:S.93, A:I.94, A:T.195, A:T.195 pi-Stacking: A:F.40, A:F.40 NAD.3: 26 residues within 4Å: Chain B: G.13, I.14, I.15, S.19, I.20, F.40, L.62, D.63, V.64, Q.65, S.93, I.94, G.95, I.121, M.146, D.147, F.148, Y.157, M.160, K.164, A.190, G.191, P.192, I.193, T.195 Ligands: THT.4 23 PLIP interactions: 23 interactions with chain B Hydrophobic interactions: B:F.148, B:A.190 Hydrogen bonds: B:G.13, B:I.20, B:D.63, B:D.63, B:V.64, B:I.94, B:G.95, B:Y.157, B:K.164, B:I.193, B:I.193, B:T.195 Water bridges: B:G.13, B:I.14, B:F.40, B:S.93, B:I.94, B:T.195, B:T.195 pi-Stacking: B:F.40, B:F.40 NAD.5: 27 residues within 4Å: Chain C: G.13, I.14, I.15, S.19, I.20, F.40, L.62, D.63, V.64, Q.65, S.93, I.94, G.95, I.121, M.146, D.147, F.148, Y.157, M.160, K.164, A.190, G.191, P.192, I.193, T.195, M.198 Ligands: THT.6 22 PLIP interactions: 22 interactions with chain C Hydrophobic interactions: C:F.148, C:A.190 Hydrogen bonds: C:G.13, C:I.20, C:D.63, C:D.63, C:V.64, C:I.94, C:G.95, C:Y.157, C:K.164, C:I.193, C:I.193, C:T.195 Water bridges: C:I.14, C:F.40, C:S.93, C:I.94, C:T.195, C:T.195 pi-Stacking: C:F.40, C:F.40 NAD.7: 26 residues within 4Å: Chain D: G.13, I.14, I.15, S.19, I.20, F.40, L.62, D.63, V.64, Q.65, S.93, I.94, G.95, I.121, M.146, D.147, F.148, Y.157, M.160, K.164, A.190, G.191, P.192, I.193, T.195 Ligands: THT.8 21 PLIP interactions: 21 interactions with chain D Hydrophobic interactions: D:F.148, D:A.190 Hydrogen bonds: D:G.13, D:I.20, D:D.63, D:V.64, D:I.94, D:G.95, D:K.164, D:I.193, D:I.193, D:T.195 Water bridges: D:G.13, D:I.14, D:F.40, D:S.93, D:I.94, D:T.195, D:T.195 pi-Stacking: D:F.40, D:F.40

4 x THT: TRANS-2-HEXADECENOYL-(N-ACETYL-CYSTEAMINE)-THIOESTER(Non-covalent)

THT.2: 10 residues within 4Å: Chain A: Q.99, M.102, F.148, A.156, Y.157, A.197, M.198, I.201, I.214 Ligands: NAD.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.148, A:F.148, A:Y.157, A:Y.157, A:I.201, A:I.201, A:I.214, A:I.214 THT.4: 10 residues within 4Å: Chain B: Q.99, M.102, F.148, A.156, Y.157, A.197, M.198, I.201, I.214 Ligands: NAD.3 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:F.148, B:F.148, B:Y.157, B:Y.157, B:I.201, B:I.201, B:I.214, B:I.214 Hydrogen bonds: B:Y.157 THT.6: 10 residues within 4Å: Chain C: Q.99, M.102, F.148, A.156, Y.157, A.197, M.198, I.201, I.214 Ligands: NAD.5 9 PLIP interactions: 9 interactions with chain C Hydrophobic interactions: C:F.148, C:F.148, C:Y.157, C:Y.157, C:I.201, C:I.201, C:I.214, C:I.214 Hydrogen bonds: C:Y.157 THT.8: 10 residues within 4Å: Chain D: Q.99, M.102, F.148, A.156, Y.157, A.197, M.198, I.201, I.214 Ligands: NAD.7 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:F.148, D:F.148, D:Y.157, D:Y.157, D:I.201, D:I.201, D:I.214, D:I.214

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rozwarski, D.A. et al., Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate. J.Biol.Chem. (1999)

Release Date

1999-09-17

Peptides

PROTEIN (ENOYL-ACYL CARRIER PROTEIN (ACP) REDUCTASE): ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

PROTEIN (ENOYL-ACYL CARRIER PROTEIN (ACP) REDUCTASE)

Related Entries With Identical Sequence